These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 9326724)
41. Comparison of uveitis induced by interleukin-8 (IL-8) and endotoxin in rabbits. Akduman L; Kaplan HJ; Ataoglu O; Or M; Bilgihan A; Hasanreisoglu B Ocul Immunol Inflamm; 1994; 2(4):223-9. PubMed ID: 22823153 [TBL] [Abstract][Full Text] [Related]
42. T-type channel blocking properties and antiabsence activity of two imidazo[1,2-b]pyridazine derivatives structurally related to indomethacin. Rimoli MG; Russo E; Cataldi M; Citraro R; Ambrosino P; Melisi D; Curcio A; De Lucia S; Patrignani P; De Sarro G; Abignente E Neuropharmacology; 2009 Mar; 56(3):637-46. PubMed ID: 19071141 [TBL] [Abstract][Full Text] [Related]
43. Novel anti-inflammatory agents based on pyridazinone scaffold; design, synthesis and in vivo activity. Abouzid K; Bekhit SA Bioorg Med Chem; 2008 May; 16(10):5547-56. PubMed ID: 18430576 [TBL] [Abstract][Full Text] [Related]
44. Synthesis and biological evaluation of some novel sulfamoylphenyl-pyridazinone as anti-inflammatory agents (Part-II * ). Bashir R; Yaseen S; Ovais S; Ahmad S; Hamid H; Alam MS; Samim M; Javed K J Enzyme Inhib Med Chem; 2012 Feb; 27(1):92-6. PubMed ID: 21612377 [TBL] [Abstract][Full Text] [Related]
45. A dual inhibitor of TNF-alpha and IL-1 mitigates liver and kidney dysfunction and improves survival in rat endotoxemia. Takeyoshi I; Yoshinari D; Kobayashi M; Kurabayashi M; Morishita Y Hepatogastroenterology; 2005; 52(65):1507-10. PubMed ID: 16201107 [TBL] [Abstract][Full Text] [Related]
47. Lipopolysaccharide-induced paw edema model for detection of cytokine modulating anti-inflammatory agents. Vajja BN; Juluri S; Kumari M; Kole L; Chakrabarti R; Joshi VD Int Immunopharmacol; 2004 Jul; 4(7):901-9. PubMed ID: 15182729 [TBL] [Abstract][Full Text] [Related]
48. Endotoxin-induced uveitis in the rat. The significance of intraocular interleukin-6. Hoekzema R; Verhagen C; van Haren M; Kijlstra A Invest Ophthalmol Vis Sci; 1992 Mar; 33(3):532-9. PubMed ID: 1544781 [TBL] [Abstract][Full Text] [Related]
49. Participation of COX, IL-1 beta and TNF alpha in formalin-induced inflammatory pain. Granados-Soto V; Alonso-López R; Asomoza-Espinosa R; Rufino MO; Gomes-Lopes LD; Ferreira SH Proc West Pharmacol Soc; 2001; 44():15-7. PubMed ID: 11793965 [No Abstract] [Full Text] [Related]
50. Inhibition of IL-1 induced articular inflammation of rats by 4-aminothiazolidines, LY 221068 and LY 269415. Chandrasekhar S; Panetta JA; Bendele AM Agents Actions; 1994 Aug; 42(1-2):67-70. PubMed ID: 7847188 [TBL] [Abstract][Full Text] [Related]
51. Anti-inflammatory effects of lipoxins on lipopolysaccharide-induced uveitis in rats. Karim MJ; Bhattacherjee P; Biswas S; Paterson CA J Ocul Pharmacol Ther; 2009 Dec; 25(6):483-6. PubMed ID: 20021273 [TBL] [Abstract][Full Text] [Related]
52. Inhibition of Hsp90 attenuates inflammation in endotoxin-induced uveitis. Poulaki V; Iliaki E; Mitsiades N; Mitsiades CS; Paulus YN; Bula DV; Gragoudas ES; Miller JW FASEB J; 2007 Jul; 21(9):2113-23. PubMed ID: 17400913 [TBL] [Abstract][Full Text] [Related]
53. IL-12 inhibits endotoxin-induced inflammation in the eye. Whitcup SM; Rizzo LV; Lai JC; Hayashi S; Gazzinelli R; Chan CC Eur J Immunol; 1996 May; 26(5):995-9. PubMed ID: 8647191 [TBL] [Abstract][Full Text] [Related]
54. Lipoxin A4 inhibits TNF-alpha-induced production of interleukins and proliferation of rat mesangial cells. Wu SH; Lu C; Dong L; Zhou GP; He ZG; Chen ZQ Kidney Int; 2005 Jul; 68(1):35-46. PubMed ID: 15954894 [TBL] [Abstract][Full Text] [Related]
55. Inhibitory effects of lutein on endotoxin-induced uveitis in Lewis rats. Jin XH; Ohgami K; Shiratori K; Suzuki Y; Hirano T; Koyama Y; Yoshida K; Ilieva I; Iseki K; Ohno S Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2562-8. PubMed ID: 16723471 [TBL] [Abstract][Full Text] [Related]
56. Anti-uveitis and inhibition of fibroblast-like corneal and conjunctival cells by interleukin-1 blockers. Xuan B; Chiou GC Inflammopharmacology; 1998; 6(2):119-32. PubMed ID: 17694369 [TBL] [Abstract][Full Text] [Related]
57. Finding a place for interleukin-1 inhibitors in the treatment of rheumatologic diseases. Finch D; Sleeman M Curr Pharm Des; 2015; 21(17):2198-205. PubMed ID: 25760298 [TBL] [Abstract][Full Text] [Related]